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Abstract
Background There are a lack of studies describing a longitu-
dinal association between preterm delivery and renal compli-
cations later in life. We assessed renal size and function in
preterm infants born with extremely low birth weight
(ELBW) during 4 years of follow-up, comparing these param-
eters to age-matched children born full term (term controls).
Methods The results of selected renal laboratory tests [levels
of cystatin C, creatinine, blood urea nitrogen (BUN)] and of
renal ultrasound evaluations were compared between the
ELBWgroup and the term control group at age 7 and 11 years.
Results The study population consisted of 64 children born
with ELBW (ELBW children) who had been recruited at birth
and 36 children born at term (term children) who took part in
both follow-up assessments. Renal ultrasound examination
revealed a significantly smaller renal volume in the 7- and
11-year-old ELBW children compared to the term controls
[right kidney volume: 50.8 vs. 61.2 ml/m2, respectively, at 7
years (p <0.01) and 51.4 vs. 58.2 ml/m2, respectively, at 11
years (p <0.01); left kidney volume: 51.4 vs. 60.3 ml/m2,
respectively, at 7 years (p <0.01) and 55.2 vs. 60.7 ml/m2,
respectively, at 11 years (p = 0.02)]. Renal function in
ELBW children was also affected. Serum cystatin C levels
were significantly higher in ELBW children than in the con-
trols at 7 years of age, and this difference remained statistically
significant at 11 years of age [0.63 vs. 0.59 mg/l, respectively,
at 7 years (p=0.02) and 0.72 vs. 0.61 mg/l, respectively, at 11
years (p = 0.01)]. Six ELBW children also had elevated
cystatin C levels (0.97–1.11 mg/l) at 11 years of age.
Cystatin C levels were within normal range in the ELBW
children at age 7 years and in term children in both follow-
up studies. BUN levels were higher in ELBW children at the
age of 11 years (4.49 vs. 4.15 mmol/l; p=0.028).
Conclusion Continued follow-up of these patients will reveal
whether the observed worsening in renal function will persist
into adulthood.
Keywords Preterm infants . ELBW . Cystain C . eGFR .
Renal ultrasound . Renal volume . Renal function . Renal
complications
Introduction
Over the past three decades the survival of extremely preterm
infants, including those born with an extremely low birth
weight (ELBW) (defined as an infant weighing <1000 g at
birth), has improved significantly, largely due to improve-
ments in the quality of prenatal, perinatal and neonatal care
[1–3]. However, many of these infants develop long-term
complications as a consequence of acute complications which
have their origin during the perinatal period [1, 4–6]. Many of
the studies reported in the literature on this subject have fo-
cused on neurological and cardiovascular complications, in-
cluding developmental delay, psychomotor dysfunction, psy-
chiatric disorders, autism and learning disabilities [7–16].
More recently, however, an increasing number of studies are
examining the association between preterm delivery, nephron
number, renal size, microalbuminuria and risk of hypertension
in adult life [17, 18]. From the physiological perspective,
nephrogenesis is an ongoing developmental process that con-
tinues until 34–36 weeks’ gestation; consequently, very
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prematurely born neonates (gestational age <32 weeks) are
likely to have a reduced number of nephrons at birth. This
deficit in nephron number has been found in several studies.
Rodriguez et al. demonstrated in an autopsy study that prema-
ture ELBW infants (gestational age <28 weeks, birth weight
≤1000 g) had markedly fewer radial glomerular counts than
term infants [19]. These authors also found that nephron num-
ber was highly correlated with gestational age. Other re-
searchers have reported that although glomerulogenesis con-
tinues until day 40 of postnatal age it never reaches the level
seen in term infants [20, 21]. Many ELBW infants are also
exposed to other risk factors associated with impaired postna-
tal renal development, such as hypoxia, hyperoxia, use of
nephrotoxic medications, acute kidney injury, nephrocalcinosis
and poor intra- and extrauterine nutrition [22–27]. Decreased
renal size has been described in adults born very preterm com-
pared to those born at full term. Authors focusing on the renal
complications of preterm birth emphasize the need for a
prolonged follow-up period for children born with ELBW (re-
ferred to hereafter as ELBW children) [28–30].
The aim of our study was to assess renal size and function
in school-age ELBW children compared to their peers and its
evolution within a 4-year observation period. We compared
the results of selected renal function laboratory tests and of
ultrasound examinations between 11-year-old ELBW children
and age-matched children born at full term (referred to here-
after as term children). We then assessed the variability of the
measured parameters over time in the ELBW group to estab-
lish a correlation between extremely preterm delivery and kid-
ney growth and function.
Methods
A cross-sectional observational study was conducted in
the outpatient paediatric department of the Polish-
American Children’s Hospital in Krakow, Poland, be-
tween 30 December 2013 and 30 April 2015. The study
cohort consisted of a study group composed of ELBW
children recruited at birth (ELBW group) and a control
group composed of composed of children enrolled in the
study at 6–7 years of age (term group). From 1 September
2002 to 31 August 31 2004, 169 newborns with a birth
weight of <1000 g were born alive in the southeast district
of Poland (Malopolska Region). All children were hospi-
talized in one of three tertiary neonatal intensive care
units (NICUs) in southeast Poland. Ninety-one infants
were discharged home from these NICUs and followed
longitudinally. All children who took part in the follow-
up assessment at 6–7 years of age were invited to partic-
ipate in the present follow-up study as well. Neonatal data
used for the study were recorded daily during the hospi-
talization of each infant in the NICU in a prospective
manner and stored on computer databases. The age-
matched term control group was formed in 2009–2010
and consisted of 38 children born with a birth weight of
>2500 g who were recruited from one general practi-
tioner’s office. All of these children were invited for a
re-assessment later in the study. The methodology and
results of the follow-up study performed when the chil-
dren were 6–7 years of age have already been published
[31].
Follow-up at 10–11 years of age
After providing informed consent, all participants underwent a
physical examination consisting of anthropometric measure-
ments, blood sampling for the assessment of cystatin C, cre-
atinine and blood urea nitrogen (BUN) levels and an ultra-
sound examination of the abdomen. The parents were also
ask to complete a questionnaire on their child’s demographic
data and health status. Both the physical examination and
completion of the questionnaire occurred during a single visit
to the paediatric outpatient department of the Polish-American
Children’s Hospital of Krakow.
Anthropometric measurements
Body height was measured to an accuracy of 1 mm using a
stadiometer with the patients standing in an upright position
with their heads in the ocular-ear position. Body weight was
measured as previously described [32]. For each patient the
standard deviation of height and weight was calculated to two
decimal points, and body surface area (BSA) was calculated
using the formula provided by Du Bois and Du Bois:
BSA=weight (kg) 0.425 × height (cm) 0.725 × 0.007184.
Serum cystatin C levels
Cystatin C was measured by a particle-enhanced
immunonephelometric assay (N Latex Cystatin C assay;
Dade Behring, Deerfield, IL) using a nephelometer (BN-II;
Dade Behring). The normal value for children between 4
and 12 years of age was defined as 0.53–0.95 mg/l. The
same method was used to evaluate cystatin C levels in chil-
dren 7 and 11 years of age.
Creatinine and BUN
Creatinine and BUN were measured by using VITROS®
Chemistry Products (Ortho Clinical Diagnostics, Raritan,
NJ). The two-point rate test for creatinine and the colorimetric
test for BUN were performed using the VITROS® 5,1 FS
Chemistry System, 950, 750, 550, 250. The normal range of
creatinine and BUN in children aged 10 and 11 years was
defined as 6.0–74.0 umol/l and 2.5–6.0 mmol/l, respectively.
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Estimated glomerular filtration rate
Estimated glomerular filtration rate (eGFR) was calculated by
using the formula provided by Hoek et al.: eGFR=−4.32+
(80.35/Cys) [33].
Renal ultrasound
Each child had two renal ultrasound examinations (Philips
EnVisor C HD system with color Doppler and C2-5 MHz
probe; Koninkli jke Phil ips N.V., Eindhoven, the
Netherlands) at ages 7 and 11 years, respectively; all ex-
aminations were performed by the same two examiners
using the same protocol for both follow–up evaluations.
For each child, kidney length and width were calculated
as the average of three measurements. Renal measurements
were performed with the subject lying in the supine posi-
tion and scanned in the para-coronal view with the trans-
ducer positioned to obtain the longest kidney dimension.
Kidney volume was calculated using the formula: (kidney
length × kidney width × kidney thickness) × Pi/6. Relative
kidney length was obtained by calculating the ratio of the
mean actual measurement to the mean renal reference mea-
surement. The reference values of kidney length were cal-
culated using the formula of Dinkel et al. [34]. Renal
length was adjusted to the patient’s height. The formula
used to calculate predicted renal length were:
Left kidney mmð Þ : 0:51346  height cmð Þ þ 17:659
Right kidney mmð Þ : 0:49915  height cmð Þ þ 18:381
The formula used to calculate relative kidney length was:
Relative kidney length ¼ actual kidney length measured by ultrasound = predicted kidney length
Relative kidney volume was established by dividing
the ultrasonographic measurements by the BSA according
to Scholbach and Weitzel [35]. The same method was
used in both groups (ELBW and term) at 7 and 11 years
of age.
Outcome variables
Primary outcomes at 10–11 years of age were: (1) presence of
small kidneys, defined as a relative kidney length of <75 % or
relative kidney volume of <45 ml/m2; (2) presence of asym-
metric kidneys, defined as a difference between relative kid-
ney volumes of >20 %; (3) abnormal serum cystatin C levels
(>0.95 mg/l). Secondary outcome variables were absolute and
relative kidney length and volume, and serum cystatin C
levels. The results obtained for the children at aged 10–
11 years were then compared to those obtained during the first
follow-up visit (at age 6–7 years).
Statistical methods
To compare the ELBW and term control groups, we used
the following tests as deemed appropriate: Mann–Whitney
U test, Fisher’s exact test, Pearson’s chi-squared test,
Welch’s t test, Student’s t test, Wilcoxon signed rank test
and Paired t test. Statistical significance was defined at
the p = 0.05 level for the two-sided test. Data were




The study group was composed of 64 children born prema-
turely (among the 78 children who participated in the first
follow-up study at 7 years of age), and the control group
was composed of 36 children born at full term (among the
38 children who participated in the first follow-up study at
7 years of age). The characteristics of the ELBW group are
presented in Table 1. Comparisons of the selected demograph-
ic and clinical variables between the ELBW and control
groups are presented in Table 2.
Children born prematurely were significantly shorter than
their peers born at term, with the mean height difference at
7 years of age reaching 1 standard deviation (z score −1.08 vs.
0.21; p <0.01) and remaining at this level 4 years later (z score
−0.88 vs. 0.20; p <0.01). The weight of the preterm children
was also significantly lower than that of their peers born at
term (7 years: z-score −0.92 vs. 0.26, p <0.01; 11 years: z-
score −0.92 vs. 0.24, p <0.01). Based on these observations,
all kidney measurements were corrected to patient’s length
(kidney length) or BSA (kidney volume).
Cystatin C, creatinine and BUN levels
Serum cystatin C levels were significantly higher in the
ELBW group than in the control group at 7 years of age
(0.63 vs. 0.59 mg/l, respectively; p=0.02), and this difference
remained statistically significant at 11 years of age (0.72 vs.
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0.61mg/l, respectively; p=0.01). Cystatin C levels were with-
in the normal range in all ELBW children at 7 years of age;
however, six ELBW children had elevated cystatin C levels
(0.97–1.11mg/l) at 11 years of age (Table 3). Cystatin C levels
were higher in ELBW children at 11 years of age than at
7 years of age, and this difference was statistically significant
(Table 4). Cystatin C levels were normal in the control chil-
dren in both follow-up studies.
The BUN and creatinine levels were not measured in chil-
dren at 7 years of age. However, they were measured in all
children at 11 years of age, revealing significantly higher
BUN levels in the ELBW children than in the term controls
(4.49 vs. 4.15 mmol/l, respectively; p=0.028) (Table 5). The
difference in serum creatinine levels between the ELBW and
term control children at 11 years of age was not statistically
significant (Table 5).
Estimated glomerular filtration rate
The eGFR values of children at 7 and 11 years of age were
significantly lower in the study (ELBW) group than in the
(full term) control group (p = 0.0116 at 7 years and
p=0.0001 at 11) years. Comparison of the eGFR in ELBW
children at 7 and 11 years of age revealed that the eGFR was
lower in these children at 11 years of age and that the differ-
ence was statistically significant (p=0.0002). Calculation of
eGFRwas based on cystatin C levels, which were measured in
both age groups.
Table 1 Characteristics of the children born with extremely low birth
weight
Characteristics of the ELBW group Values
Birth weight (g) 875 (750–960)
Gestational age (weeks) 27 (25–28)
Five-minute Apgar score 6 (5–7)
Small for gestational age 19 (30 %)
Treatment with prenatal steroids 31 (48 %)
Mechanical ventilation 58 (91 %)
Administration of surfactant 49 (77 %)
PDA treatment 19 (30 %)
Oxygen on 28th day of life 44 (69 %)
Oxygen at 36 weeks postmenstrual age 26 (41 %)
IVH grade III or IV 6 (9 %)
Weight gain during NICU stay 18 (15–23)
Length of hospitalization (days) 81 (56–106)
Data are presented as the number of patients with the percentage given in
parenthesis or as the median with the 25th-75th percentile [interquartile
range (IQR)] given in parenthesis, as appropriate
ELBW, Extremely low birth weight; PDA, patent ductus arteriosus; IVH,
intraventricular haemorrhage; NICU, neonatal intensive care uni)
Table 2 Comparison of selected demographic and clinical variables between the infants born with extremely low birth weight (ELBW children) and
infants born at term (control children)
Demographic and clinical variables Control (full term) group (n= 36) Study (ELBW) group (n= 64) p valuea
Demographic variables
Female 17 (47 %) 43 (67 %) 0.06b
Birth weight (g) 3570 (3395–3880) 875 (750–960) <0.01c
Gestational age (weeks)) 40 (39–40) 27 (25–28) <0.01c
Vaginal delivery 31 (86 %) 13 (20 %) <0.01b
Multiple pregnancy 0 9 (14 %) 0.024b
Small for gestational age 2 (6 %) 19 (30 %) 0.004b
First follow-up (at age 7 years)
Age at evaluation (years); median (25th-75th percentile) 6.9 (6.4–7.4) 6.5 (6.4–6.8) 0.04c
Height (cm) 124 ± 7.4 116 ± 6.3 <0.01d
Height (z score) 0.21 ± 1.0 −1.08 ± 1.3 <0.01d
Weight (kg) 25.2 ± 5.3 19.5 ± 3.8 <0.01d
Weight (z score) 0.26 ± 1.2 −0.92 ± 1.3 <0.01d
Second follow-up (at age 11 years)
Age at evaluation (years) 10.7 (10.2–11.1) 11 (10.8–11.3) 0.01c
Height (cm) 146 ± 8 141 ± 8 <0.01d
Height (z score) 0.20 ± 1.1 −0.88 ± 1.2 <0.01d
Weight (kg) 40.4 ± 9.9 33.7 ± 8.2 <0.01d
Weight (z score 0.24 ± 1.2 −0.92 ± 1.3 <0.01d
Data are presented as the number of patients with the percentage given in parenthesis, the median with the IQR given in parenthesis and the mean ±
standard deviation (SD), as appropriate
a Statistical significance was defined at the p= 0.05 level for the two-sided test
b p value using the Fisher exact test
c p value using the Mann–Whitney U test
d p value using Student’s t test
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Results of renal ultrasound
Mean values of all renal measurements were significantly
lower in the ELBW group compared to the term control group
at 11 years of age, and this was seen at 7 years of age as well,
as shown in Table 6. In 19 children from the study group
relative kidney volume was less than 45 ml/m2 at 11 years
of age. This difference was statistically significant when com-
pared to the control group at the same age. A difference be-
tween those two groups was also observed at the age of
7 years. Asymmetric kidneys were found in 8 children from
the ELBW group, compared to 3 in the control group at
11 years of age (p=0.7). At the time of the first follow-up
we observed asymmetric kidneys in 12 ELBW children and
1 term child (p=0.02). These results are shown in Table 3.
Discussion
The focus of this study was an analysis of the renal function of
children born with ELBW in comparison to that of children
born full term, at 11 years of age. We observed and compared
the renal function of the same cohort of children for 4 years
[31] and assessed the growth of the kidney over that same
period of time. The children who participated in our
multicentre study come from three tertiary referral centres in
the Malopolska region of Poland, which makes the study co-
hort complete and representative, with a high percentage of
observation (up to 82 % of the 7-year-old cohort). We used
anthropometric standards based on the Polish population [32].
Renal ultrasound standardization was crucial for the reliability
of the study. Based on the observation that ELBW children
were shorter and weighed less than children in the control
group, we therefore corrected kidney measurements to each
child’s height (kidney length) and BSA (kidney volume).
Renal ultrasound examinations were performed by the same
certified examiners, using the same protocol in both follow–
up evaluations. The same outcomes and cut-off points in mea-
surements were set in the assessment of kidney function and
growth in both groups of children at 7 and 11 years of age.
One of the greatest strengths of our study is the evaluation
of the same cohort over a 4-year period, and we believe that a
major limitation is that the cohort of ELBW children was
incomplete at the examination at 11 years of age. Those chil-
dren who missed the second follow-up assessment were the
same (as a group) in terms of gestational age, maturation,
Table 3 Primary outcome variables for extremely low birth weight (ELBW) children and control children




p value according to the Fisher
exact test
First follow-up (at age 7 years)
Relative kidney length <75 % of normal value 0 1 1.0
Relative kidney volume < 45 ml/m2 1 21 <0.01
Asymmetric kidneys (difference > 20 %) 1 12 0.02
High serum cystatin C level (>0.95 mg/l) 0 0 1.0
Second follow-up (at the age of 11 years)
Relative kidney length <75 % of normal value 0 3 0.55
Relative kidney volume < 45 ml/m2 1 19 <0.01
Asymmetric kidneys (difference > 20 %) 3 8 0.7
High serum cystatin C level (>0.95 mg/l) 0 6 0.08
Data are presented as the number of children
Table 4 Results of paired t-test for selected biochemical and ultrasonographic measurements








Relative right kidney volume difference between 1st and
2nd follow-up (ml/m2)
−2.6 (−7.4 to −2.01) 0.25 0.33 (−2.6 to 3.3) 0.82
Relative left kidney volume difference between 1st and
2nd follow-up (ml/m2)
0.82 (−4.02 to 5.7) 0.78 3.7 (−0.4 to 7) 0.11
Cystatin C difference between 1st and 2nd follow-up
(mg/l)
0.01 (−0.03 to 0.06) 0.51 0.10 (0.05–0.14) <0.001
Data are presented as the mean difference with the 95 % confidence interval (CI) for difference given in parenthesis
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premature birth complications and renal findings at the age of
6–7 years (data on request).
Renal size
In our study, renal ultrasound revealed that the ELBW
children had significantly smaller renal volumes at 7 and
11 years of age that the age-matched term controls.
Kaijzer-Veen et al. [30] evaluated young adults (20 years
of age) who had been born very preterm (<32 weeks of
gestation), either small or appropriate for gestational age
(SGA and AGA, respectively). This 20-year observation
period is the longest reported to date. Their analysis re-
vealed that both the absolute and relative kidney length
and volume were significantly lower in SGA and AGA
children (in particular, the left kidney and in women) than
young adults born full term. However, their data consisted
of just a single measurement taken at 20 years of age; no
other measurements were obtained during the childhood
period. In comparison to the study population of Kaijzer-
Veen et al. [30], the preterm subjects in our study were
more immature (in terms of gestational age, up to 81 %
were born at <30 weeks of gestation) and had a lower
birth weight {<1500 g (Kaijzer-Veen et al.’s study [30])
vs. <1000 g (our study)}. Different conclusions were
drawn Rakow et al. [36] who found that the total renal
volume correlated with birth weight but did not observe
significant differences with in terms of renal function or
volume between preterm, term SGA and term AGA
groups. The authors assessed children born preterm at
Table 5 Comparison of the results of renal function tests between extremely low birth weight (ELBW) children and control children
Renal function tests Control (full term) group (n= 36) Study (ELBW) group (n= 64) p value according to Student’s t test
First follow-up (at age 7 years)
Serum cystatin C level (mg/l) 0.59 ± 0.08 0.63 ± 0.07 0.02
Second follow-up (at age 11 years)
Serum Cystatin C level (mg/l) 0.61 ± 0.08 0.72 ± 0.15 0.01
BUN (mmol/l) 4.15 ± 0.94 4.49 ± 1.03 0.028
Creatinine (umol/l) 46.3 ± 7.6 43.2 ± 7.7 0.08
Data are presented as the mean ± SD
BUN, Blood urea nitrogen
Table 6 Comparison of the results of ultrasonographic measurements between extremely low birth weight (ELBW) children and control children
Ultrasonographic
measurements
First follow-up (at age 7 years) Second follow-up (at age 11 years)









Absolute right kidney length
(cm)
8.07 ± 0.65 7.35 ± 0.65 <0.01 8.97 ± 0.95 8.29 ± 0.89 <0.01
Absolute left kidney length
(cm)
8.06 ± 0.72 7.37 ± 0.72 <0.01 9.04 ± 0.99 8.39 ± 0.89 <0.01
Absolute right kidney volume
(ml)
58 ± 14 40 ± 10 <0.01 75 ± 20 59 ± 15 <0.01
Absolute left kidney volume
(ml)
57 ± 15 41 ± 11 <0.01 78 ± 20 64 ± 17 <0.01
Relative right kidney length
(%)
99.8 ± 6 96.6 ± 7 0.02 98.2 ± 8 93.1 ± 9 <0.01
Relative left kidney length (%) 98.4 7 95.6 ± 7 0.08 97.3 ± 9 92.9 ± 8 <0.01
Relative right kidney volume
(ml/m2)
61.2 ± 11 50.8 ± 10 <0.01 58.2 ± 10 51.4 ± 10 <0.01
Relative left kidney volume
(ml/m2)
60.3 ± 12 51.4 ± 12 <0.01 60.7 ± 10 55.2 ± 12 0.02
Data are presented as the mean ± SD
a p value according to Student’s t test
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<32 gestational weeks, term but small for gestational age
(SGA) and term appropriate for gestational age (AGA) at
9–12 years of age. However, as mentioned above, the
children assessed in our study were more immature at
birth.
Renal function
Our study revealed that renal function was impaired in our
study group of ELBW children. At 7 years of age, cystatin
C levels were within the normal range in all children of this
group, but at the second follow-up, cystatin C levels were
above the normal range in six 11-year-old ELBW children,
although the difference did not reach statistical significance. It
should be emphasized that cystatin C levels did change over
the 4-year follow-up period, which demonstrates that there is a
tendency toward worsening renal function in ELBW children
with age and suggests that such children need further obser-
vation. All children with increased cystatin C levels were re-
ferred to the pediatric nephrology department for further
counselling. As an additional parameter we calculated the
eGFR in both groups based on cystatin C levels. Creatinine
levels in the study which took place at 7 years of age were not
measured so we could not calculate eGFR using standard
formulas when comparing both age groups. However, there
are several studies that have found that both cystatin C and
creatinine levels correlate with eGFR in adults and in children
[37–39]. Bacchetta et al. showed that cystatin C-derived for-
mulas for estimating eGFR seemed to be accurate in non-
selected paediatric patients [40]. Furthermore, serum creati-
nine level (but not cystatin C level) has been found to correlate
with the lean mass of the body. Therefore, cystatin C seems to
be a more adequate alternative for the assessment of renal
function [41]. Moreover, in ELBW children who were shorter
and thinner at follow-up, cystatin C concentrations may reflect
eGFR even more accurately than serum creatinine levels [42].
Our study demonstrated that ELBW children had a signifi-
cantly lower eGFR at 7 and 11 years of age compared to term
children of the same age. We found that the eGFR had de-
creased over the 4-year observation period and that it was
significantly lower at 11 years of age than at 7 years of age.
However, the study by Rakow et al. found no significant dif-
ferences in renal function between preterm and term groups
(AGA and SGA) [36]. It is important to note that their study
focused on a high-risk population with multi-systemic com-
plications that could, at least potentially, affect renal function.
Our first follow-up study at 7 years of age showed that SGA
and poor weight gain during NICU hospitalization stay were
risk factors for renal complications in the ELBW group [31].
Kist-van Holthe et al. [26] evaluated 42 children at the age of
7.5 (±1.0) years who had been born preterm at a gestational
age of <32 weekswith nephrocalcinosis. These authors report-
ed that more preterm children with neonatal nephrocalcinosis
had mild chronic renal insufficiency (defined as GFR of
<85 ml/min/1.73 m2) in comparison to term and preterm chil-
dren without nephrocalcinosis. The study shows that prema-
turity per se is associated with high blood pressure and rela-
tively small kidneys despite nephrocalcinosis [26].
In conclusion, our data demonstrate that both kidney size
and function were affected by preterm birth in children with
ELBW and that this trend continued during the 4-year obser-
vation period. It would appear that the kidneys of ELBW
children are programmed to be smaller and that renal function
deteriorates with time. Continued follow-up of these patients
will show whether this observed worsening in renal function
will persist into adulthood.
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